AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,750,000 | +26.8% | 317,000 | -4.2% | 0.00% | 0.0% |
| Q2 2020 | $4,534,000 | +16.6% | 330,979 | +21.7% | 0.00% | 0.0% |
| Q1 2020 | $3,889,000 | -54.3% | 272,020 | -45.9% | 0.00% | 0.0% |
| Q4 2019 | $8,516,000 | +115.1% | 502,782 | +95.4% | 0.00% | 0.0% |
| Q3 2019 | $3,960,000 | -31.4% | 257,311 | +4.5% | 0.00% | 0.0% |
| Q2 2019 | $5,776,000 | -15.3% | 246,320 | +2.3% | 0.00% | -50.0% |
| Q1 2019 | $6,821,000 | -49.7% | 240,797 | -46.5% | 0.00% | 0.0% |
| Q4 2018 | $13,564,000 | +85.2% | 450,068 | +115.3% | 0.00% | 0.0% |
| Q3 2018 | $7,322,000 | +52.0% | 209,084 | +2.9% | 0.00% | +100.0% |
| Q2 2018 | $4,816,000 | -9.2% | 203,131 | -1.9% | 0.00% | -50.0% |
| Q1 2018 | $5,304,000 | +49.4% | 207,139 | +1.3% | 0.00% | +100.0% |
| Q4 2017 | $3,550,000 | -36.3% | 204,540 | +1.6% | 0.00% | -50.0% |
| Q3 2017 | $5,572,000 | – | 201,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|